ERBB2 and breast carcinoma: Overactivation of ErbB2 signaling leads to activation of the transcription factor MZF1 which in turn increases the expression of the lysosomal cholesterol transporter NPC1 and activates macropinocytosis, increasing the macropinocytotic uptake of extracellular cholesterol in breast cancer cells [7].